View On IC.GC.CA

REGISTERED

on 25 Jan 2023

Last Applicant/ Owned by

EPIRIUM BIO INC.

9171 Towne Centre Drive, Suite 270San Diego CA 92122

Serial Number

2049494 filed on 23^rd Jul 2020

Registration Number

TMA1162294 registered on 25^th Jan 2023

Registration expiry Date

23^rd Jul 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

E

Trademark usage description

pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the tr Read More

Vienna Information

1 . 15 . 15

DropsGouttes

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 21

One letterUne lettre

24 . 17 . 24

Pin iconsIcônes épingles pointeurs

Classification Information

Class [005]
Pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the treatment of the central nervous system namely central nervous system diseases and disorders that affect movement; steroids.

Classification kind code

Mark Details

Serial Number

2049494

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 7^th Jan 2022	Agent Changed
Submitted for opposition 22 on 22^nd Dec 2021	Search Recorded
Submitted for opposition 20 on 22^nd Dec 2021	Examiner's First Report
Submitted for opposition 223 on 22^nd Dec 2021	Total Provisional Refusal
Submitted for opposition 256 on 5^th Jul 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 3^rd Sept 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 2^th Sept 2020	Created
Submitted for opposition 31 on 2^th Sept 2020	Formalized
Submitted for opposition 228 on 23^rd Jul 2020	International Registration
Submitted for opposition 30 on 23^rd Jul 2020	Filed

E

Classification Information

Class [005]Pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the treatment of the central nervous system namely central nervous system diseases and disorders that affect movement; steroids.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the treatment of the central nervous system namely central nervous system diseases and disorders that affect movement; steroids.